Pharmaceuticals, Biotechnology and Life Sciences
Analysis of Blood Samples from Patients who Responded to the BriLife® Vaccine During Phase 2 Trial Suggests that the Same…
NEWCASTLE UPON TYNE, UK, 26 NOVEMBER 2021. QuantuMDx Group Limited (“QuantuMDx”), today confirms that both its SARS-CoV-2 assays for open…
MALVERN, Pa., Nov. 26, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and…
Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health Authorities.This marks the fourth new…
Comment on the interview for the journal Dienas Bizness The Management Board of “Olainfarm” got acquainted with the interview with…
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic – Articles of Association
All proposals of the Board of Directors approved Audited statutory interim financial statements (standalone financial statements) of the Company as…
COPENHAGEN, Denmark, November 26, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company’s share capital has been…
Bagsværd, Denmark, 26 November 2021 – Novo Nordisk today announced that the company has received the results from the Volume…
The Phase 2 trial will evaluate SCB-2019 (CpG 1018/Alum) as a booster dose in individuals previously vaccinated with CoronaVac or…